RG
HZNP

Renaissance Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Renaissance Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,917
Closed -$453K – 279
2023
Q3 		$453K Sell
3,917
-1,226
-24% -$132K 0.02% 224
2023
Q2 		$529K Sell
5,143
-253,772
-98% -$26.8M 0.02% 222
2023
Q1 		$28.3M Sell
258,915
-27,725
-10% -$3.06M 1.3% 38
2022
Q4 		$32.6M Sell
286,640
-130,769
-31% -$10.9M 1.6% 3
2022
Q3 		$25.8M Buy
417,409
+118,902
+40% +$8.31M 1.39% 23
2022
Q2 		$23.8M Sell
298,507
-1,178
-0.4% -$112K 1.23% 42
2022
Q1 		$31.5M Sell
299,685
-2,088
-0.7% -$203K 1.42% 18
2021
Q4 		$32.5M Sell
301,773
-10,740
-3% -$1.17M 1.32% 31
2021
Q3 		$34.2M Sell
312,513
-2,759
-0.9% -$286K 1.48% 8
2021
Q2 		$29.5M Sell
315,272
-74,961
-19% -$6.9M 1.24% 35
2021
Q1 		$35.9M Sell
390,233
-15,150
-4% -$1.28M 1.52% 3
2020
Q4 		$29.7M Sell
405,383
-65,686
-14% -$4.88M 1.27% 24
2020
Q3 		$36.6M Sell
471,069
-47,284
-9% -$3.25M 1.69% 3
2020
Q2 		$28.8M Buy
518,353
+437,270
+539% +$18.7M 1.37% 11
2020
Q1 		$2.4M Buy
+81,083
New +$2.74M 0.13% 109
2017
Q1 		– Sell
-16,253
Closed -$263K – 313
2016
Q4 		$263K Buy
+16,253
New +$295K 0.01% 258

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Renaissance Group's HZNP Position: Q4 2023 in Review

Renaissance Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,917 shares — an estimated $453K sold.

Renaissance Group first reported a position in HZNP in Q4 2016 and held it in 16 quarters. The position peaked at $36.6M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Renaissance Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Renaissance Group sold 3,917 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $453K.
  • Renaissance Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 16 quarters.
  • Renaissance Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $36.6M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Renaissance Group's 13F filing for Q4 2023, filed 9 Feb 2024.